Insulin resistance in this group of patients results from defects at the molecular level, including impaired insulin receptor-related signaling pathways enhanced by obesity and its features: Excess visceral fat, chronic inflammation, and reactive oxygen species. This evidence concerns the gene INSR and obesity due to melanocortin 4 receptor deficiency.